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Modifications of plant immune complexes by
secreted pathogen effectors can trigger strong im-
mune responses mediated by the action of nucleo-
tide binding-leucine-rich repeat immune receptors.
Although some strains of the pathogen Pseudo-
monas syringae harbor effectors that individually
can trigger immunity, the plant’s response may be
suppressed by other virulence factors. This work re-
veals a robust strategy for immune suppression
mediated by HopZ3, an effector in the YopJ family
of acetyltransferases. The suppressing HopZ3
effector binds to and can acetylatemultiplemembers
of the RPM1 immune complex, as well as two
P. syringae effectors that together activate the
RPM1 complex. These acetylations modify serine,
threonine, lysine, and/or histidine residues in the tar-
gets. Through HopZ3-mediated acetylation, it is
possible that the whole effector-immune complex is
inactivated, leading to increased growth of the path-
ogen.
INTRODUCTION
Post-translational modifications (PTMs) can modulate protein
activity, stability, interactions with other macromolecules, and
subcellular localization (Karve and Cheema, 2011; Salomon
and Orth, 2013). PTMs are often rapidly acquired, reversible,
and highly regulated (Deribe et al., 2010). In plant defense re-
sponses to pathogenic bacteria, phosphorylation, a common
PTM, can play a critical role in the early stages of signal transduc-
tion. For example, in response to a fragment of bacterial flagellin
called flg22, the flagellin receptor (FLS2) becomes rapidly phos-
phorylated, which is important for downstream signaling events
that confer disease resistance (Asai et al., 2002). Phosphoryla-
tion also can be important for immunity conferred through com-
plexes that contain intracellular nucleotide binding-leucine-rich
repeat (NB-LRR) receptor proteins encoded by resistance genes
(Ellis and Dodds, 2003; Liu et al., 2011; Oh and Martin, 2011).1670 Cell Reports 13, 1670–1682, November 24, 2015 ª2015 The AuSome NB-LRR protein complexes contain kinases that are
important for sensing type III secreted effectors and can lead
to receptor-mediated immune signaling (e.g., RPM1/RIPK and
PRF/PTO) (Liu et al., 2011; Mucyn et al., 2006).
NB-LRR proteins are triggered to signal upon direct binding or
indirect interactions with a limited number of specific cognate
pathogen effectors (Chisholm et al., 2006; Deslandes and Rivas,
2012; Jones andDangl, 2006). Several type III-secreted effectors
from the bacterial pathogen P. syringae activate NB-LRRs by
modifying proteins that bind to NB-LRRs (Bent et al., 1994; Grant
et al., 1995; Simonich and Innes, 1995). One such NB-LRR-inter-
acting protein is RIN4, an intrinsically disordered hub protein that
interacts with several components of the RPM1 defense com-
plex (Sun et al., 2014). RIN4 is a major target of effector modifi-
cation (Liu et al., 2011; Mackey et al., 2002, 2003; Wilton et al.,
2010). In Arabidopsis, when effectors either stimulate RIN4
phosphorylation of threonine 166 (RIN4-pT166) or cleave RIN4,
signaling is activated through the NB-LRRs RPM1 or RPS2,
respectively (Liu et al., 2011; Mackey et al., 2002, 2003).
Some bacterial effectors from plant pathogens can be identi-
fied by their ability to trigger plant immunity when expressed in
heterologous pathogen strains. This approach works because
the immune-inducing activity is usually phenotypically dominant
to the virulence activities of other effectors (Gabriel et al., 1986;
Shen and Keen, 1993; Staskawicz et al., 1984; Whalen et al.,
1988). However, the activity of an immune-inducing effector
can be masked by the presence of other effectors encoded by
the same bacteria (Tsiamis et al., 2000; Szczesny et al., 2010).
By studying effectors from the same or different strains on the
same plant, it has been shown that some effectors can suppress
cell death induced bymultiple effectors (Jamir et al., 2004; Vinat-
zer et al., 2006). Additionally, cell death induced by a single
effector can be suppressed by multiple effectors from the
same strain (Guo et al., 2009). Understanding the basis of this
within-strain masking is important for discerning the mechanism
of pathogenesis and predicting changes in pathogenicity in the
field due to the acquisition or loss of effectors.
P. syringae pv. syringae strain B728a (PsyB728a) grows both
epiphytically (associated with plant epidermal cells) and endo-
phytically (associated with plant mesophyll cells), in a manner
that depends on type III effectors (Hirano et al., 1999; Lee
et al., 2012b; Vinatzer et al., 2006). Transient expression of pairsthors
of effectors from PsyB728a in Nicotiana benthamiana showed
that the HopZ3 effector can suppress cell death induced by at
least four other PsyB728a effectors (Vinatzer et al., 2006).
Furthermore, PsyB728a lacking HopZ3 (PsyDhopZ3) shows
reduced growth onArabidopsis and tomato (Lee et al., 2012b; Vi-
natzer et al., 2006), suggesting that HopZ3 normally suppresses
effector-induced immunity in these plants.
HopZ3 is a member of the YopJ family of effectors, which are
found in many plant and animal pathogens (Lewis et al., 2011).
YopJ family members typically require conserved histidine
(His) and cysteine (Cys) residues proposed to be important for
catalysis (Lee et al., 2012b; Lewis et al., 2011; Mukherjee et al.,
2006). YopJ and VopA, effectors of Yersinia pestis and Vibrio
parahaemolyticus, respectively, acetylate mitogen-activated ki-
nase kinases to block host immunity (Mittal et al., 2010; Mukher-
jee et al., 2006; Trosky et al., 2007). Both YopJ and VopA can
acetylate lysine (Lys), serine (Ser), and threonine (Thr) in target
proteins (Mukherjee et al., 2006; Trosky et al., 2007). A common
feature of several YopJ family proteins is that their acetyltransfer-
ase activities are strongly stimulated by the eukaryotic co-factor
inositol hexakiphosphate (IP6) (Lee et al., 2012a; Ma et al., 2015;
Mittal et al., 2010).
Only one YopJ family effector from a bacterial plant path-
ogen (PopP2 from Ralstonia solanacearum) was shown to
cause in planta acetylation of a substrate (Le Roux et al.,
2015; Sarris et al., 2015). Two other YopJ family proteins
from plant pathogens, HopZ1a from P. syringae and AvrBsT
from Xanthomonas euvesicatoria, also were found to have ace-
tyltransferase activity in vitro on one or more potential sub-
strates. Acetylation activity requires the conserved catalytic
Cys or His (Cheong et al., 2014; Jiang et al., 2013; Lee et al.,
2012a; Lewis et al., 2013).
This study addresses the mechanism of HopZ3 immune
suppression in Arabidopsis through acetylation of multiple
targets. We propose that modification of several components
in a plant-effector complex can explain how immunity is
attenuated.
RESULTS
HopZ3 Interacts with Multiple Members of an Immune
Complex as well as Additional Defense Proteins
To find clues about how HopZ3 promotes PsyB728a growth in
Arabidopsis (Vinatzer et al., 2006), we mined data from ongoing
high-throughput experiments in which interactions between and
among libraries of pathogen effectors and plant immune-
signaling components were tested pairwise in targeted Y2Hmat-
ing assays. We also performed a genome-wide Y2H screen with
HopZ3 as the bait (Figure S1A; Table S1).
HopZ3 interacted with the Arabidopsis proteins RIN4 and
several kinases, most of which belong to the receptor-like cyto-
plasmic kinase (RLCK) family (members RIPK, PBS1, BIK1, and
PBL1) and one of which is a mitogen-activated protein kinase,
MPK4 (Figure S1A; Table S1). Interestingly, HopZ3 also inter-
acted with the PsyB728a effectors AvrB3 and AvrRpm1Psy as
well as proteins encoded by orthologous alleles of these pro-
teins from other P. syringae strains (AvrB and AvrRpm1, respec-
tively). However, HopZ3 did not interact with itself or theCell RepHopI1Psy effector (Figure S1A; Table S1). For selected proteins,
we confirmed that they were expressed in yeast, including
HopI1Psy, the negative control in the Y2H assay (Figure S1B).
Using bimolecular fluorescence complementation (BIFC), co-
immunoprecipitation (coIP), and/or pull-down assays, we
corroborated many of the positive Y2H protein-protein interac-
tions either in planta or in vitro (Figures 1A and 1B; Figures
S1C–S1E; Table S1). HopZ3 did not interact with itself or
HopI1Psy as assayed by either BIFC or pull-down (Figures 1A
and 1B). Some HopZ3 interactors previously were shown to
form complexes (e.g., RIN4-RIPK, RIPK-AvrB, RIN4-AvrB,
RIN4-AvrRpm1, AvrB-MPK4, and RIN4-MPK4) (Cui et al.,
2010; Liu et al., 2011; Mackey et al., 2002). Interestingly,
PsyB728a effectors that bound to HopZ3 also could bind to
each other (e.g., AvrB3-AvrRpm1Psy, AvrB3-AvrB3, and
AvrRpm1Psy-AvrRpm1Psy) (Figure S1A; Table S1).
As several components of RPM1 immune complexes
(e.g., RIN4, RIPK, AvrB, and AvrRpm1) were among the HopZ3
interactors, we tested whether the virulence effect of HopZ3
depended on RPM1. In rpm1 plants, PsyDhopZ3 and a comple-
mented strain expressing HopZ3 grew to the same level as bac-
teria-expressing HopZ3 in wild-type (WT) plants. Thus, HopZ3
promotes bacterial growth by suppressing RPM1 immunity
(Figure 1C).
Interacting Partners Direct HopZ3 to the Cell Periphery
Using the BIFC results as an indicator of localization, most of the
interactions between HopZ3 and other proteins, except for the
HopZ3-MPK4 interaction, occurred at the cell periphery (Fig-
ure 1A; Figure S1F). This fits with the fact that most HopZ3-inter-
acting proteins function at the plasma membrane (Kim et al.,
2005; Liu et al., 2011; Nimchuk et al., 2000). HopZ3 expressed
on its own in plants is mainly cytoplasmic and nuclear (Lee
et al., 2012b; Lewis et al., 2008). The lack of membrane localiza-
tion could be due to the competition between higher endoge-
nous levels of cytosolic/nuclear (e.g., MPK4) (Andreasson
et al., 2005) versus membrane protein interactors (e.g., RIPK/
RIN4) (Kim et al., 2005; Liu et al., 2011).
To further test whether an interactor can change the subcellu-
lar location of HopZ3, we used a fractionation approach with
fusion versions of HopZ3 and AvrB3 that retain their biological
activity in planta (Lee et al., 2012b; Vinatzer et al., 2006).
AvrB3, like AvrB, contains a predicted N-terminal myristoylation
motif that targets the protein to the plant plasma membrane
(Nimchuk et al., 2000). To investigate whether the presence of
AvrB3 alters the localization of HopZ3, wemutated the myristoy-
lation site in AvrB3 to create a Gly to Ala (G2A) substitution. The
G2A mutation caused mislocalization of the AvrB3-GFP fusion
protein (Figure S2A). Simultaneous co-expression of HopZ3
with AvrB3 directly in plants caused HopZ3 to partition with the
membrane fraction (Figure 1D). However, when AvrB3_G2A
was co-expressed with HopZ3, membrane localization was
mostly lost (Figure 1D). Thus, at least one interacting effector
from PsyB728a can stably recruit HopZ3 to the membrane frac-
tion. Together with the HopZ3-AvrB3 BIFC signal at the cell pe-
riphery, the fractionation analysis of HopZ3 in the presence of
AvrB3 is consistent with the known location of RPM1
components.orts 13, 1670–1682, November 24, 2015 ª2015 The Authors 1671
Figure 1. HopZ3 Interacts with RIN4, RIPK,
AvrRpm1Psy, and AvrB/B3
(A) Reconstituted YFP fluorescence (BIFC) of con-
structs coexpressed in N. benthamiana was
monitored 2 days after transformation. HopZ3-
nYFP with HopI1Psy-cYFP or HopZ3-cYFP was
used as a negative control. Bar represents 20 mm.
See also Figure S1E and Table S1.
(B) HopZ3 directly interacts with RIPK, AvrB,
AvrB3, and RIN4. (Left) In vitro pull-down assays
with purified recombinant GST-RIPK and His-
HopZ3 (Z3), His-HopZ3_C300A (C/A), or His-
HopI1Psy (I1) are shown. The presence of HopZ3
variants in the GST pull-down was detected with
His antibody. (Right) Recombinant GST-HopZ3
immobilized on gluthathione agarose was incu-
bated with extracts from E. coli expressing His-
tagged AvrB, AvrB3, RIN4, or control HopI1Psy.
Proteins pulled down were detected with GST
(top) and His (bottom) antibodies. Expected pro-
teins are marked by white asterisks and
the background band by a red asterisk. Note that
the expected size of AvrB3-His is similar to the
background band (lane 3). In shorter exposure
(lane 9), AvrB3 can be distinguished from the
background band.
(C) HopZ3 inhibits RPM1-mediated defense. Col
(WT) and rpm1 leaves were infiltrated with
PsyDhopZ3 containing empty vector pME6010
(vector 1) or HopZ3. PsyDhopZ3/vector1 had
growth defect only in Col (WT) 3 days post-infil-
tration (dpi). Error bars are SE (n = 8; *p < 0.5,
t test).
(D) AvrB3 and HopZ3 co-localize in microsomal
fraction. HopZ3-GFP was detected mostly in the
soluble fraction when transiently expressed in
N. benthamiana alone or with AvrB3_G2A-HA
(myristoylation mutant), but it was present mostly in the microsomal fraction when expressed with AvrB3-HA. Expressed proteins were detected with GFP and
HA antibodies. H+-ATPase and fructose-1,6-bisphosphatase (FBP) served as markers for membrane and soluble proteins, respectively. See also Figure S1 and
Table S1.RPM1-Mediated Immunity Is Activated by AvrB3 and
AvrRpm1Psy
TwoHopZ3 interactors (AvrB3 and AvrRpm1Psy) are homologs of
effectors (AvrB and AvrRpm1, respectively) that stimulate RPM1
immunity (Bisgrove et al., 1994; Liu et al., 2011; Mackey et al.,
2002; Ritter and Dangl, 1995). One possibility to explain why
PsyDhopZ3 has reduced growth relative to PsyB728a is that
AvrB3 and/or AvrRpm1Psy trigger RPM1 immunity that is nor-
mally inhibited by HopZ3.
We first assessed if AvrB3 and AvrRpm1Psy trigger RPM1-
dependent signaling using a heterologous P. syringae strain
that lacks these effectors. We monitored the growth of
P. syringae pv. tomato DC3000 (PtoDC3000) expressing AvrB3
(PtoDC3000/AvrB3) in WT or rpm1-deficient plants. AvrB3 sup-
pressed growth of PtoDC3000 only in the WT background, indi-
cating that it triggers RPM1-dependent signaling (Figure 2A).
However, the AvrB3_G2A mutant that was mislocalized due to
the lack of its myristoylation site (Figure 1D) did not inhibit bacte-
rial growth (Figure 2A). As expected, PtoDC3000/AvrB3 induced
RIN4-pT166 after infection, a hallmark of RPM1-mediated
signaling. However, the level of RIN4-pT166 was not as high as
that found after PtoDC3000/AvrB infection (Figure 2B). In Y2H1672 Cell Reports 13, 1670–1682, November 24, 2015 ª2015 The Auand in planta BIFC assays, AvrB3 interacted with both RIPK
and RIN4 (Figures S1A and S2B). Thus, AvrB3 has many similar
effects as reported for AvrB (Liu et al., 2011;Mackey et al., 2002).
Unlike AvrB3, PtoDC3000 expressing AvrRpm1Psy (PtoDC3000/
AvrRpm1Psy) did not induce detectable growth suppression or
RIN4-p166 after infection (Figures 2B and 2C).
We next assessed the roles of AvrB3 and AvrRpm1 using
various deletion mutants of PsyB728a. Deletion of AvrB3,
AvrRpm1Psy, or both effectors did not change the in planta
growth of bacteria (Figure 2D). However, compared with
PsyDhopZ3, a strain that also lacked AvrB3, AvrRpm1Psy or
both effectors showed increased growth (Figure 2D). This sug-
gests that AvrB3 and AvrRpm1Psy must be delivered together
from their native strain to activate immunity, possibly due to their
interaction (Figure 1A; Figure S1A). The increased growth of
PsyDhopZ3DavrRpm1Psy or PsyDhopZ3DavrB3 was comple-
mented by plasmid-borne copies of AvrRpm1Psy or AvrB3,
respectively (Figure 2E).
Finally, we tested the effect of expressing HopZ3 directly in
Arabidopsis (Figure S2C). These plants promoted the growth of
strains that are usually suppressed by RPM1 signaling
(PtoDC3000/AvrB and PtoDC3000/AvrRpm1). The effect ofthors
Figure 2. HopZ3 Suppresses Recognition of
Effectors that Trigger RPM1 Signaling
(A) Immunity induced by AvrB3 requires RPM1
in Arabidopsis. Col (WT) and rpm1 leaves were in-
filtrated with PtoDC3000 expressing AvrB3,
AvrB3_G2A, or an empty vector. Only Pto/AvrB3
strain had a growth defect in WT plants 3 dpi.
Different letters indicate significant difference (p <
0.05, ANOVA and Fisher’s least significant differ-
ence [LSD] test; n = 12).
(B) The RIN4 T166 phosphorylation by PtoDC3000
expressing AvrB3 and AvrRpm1Psy. Col (WT)
plants were infiltrated with OD600 = 0.1 of
PtoDC3000 containing an empty vector, AvrB
(positive control), AvrB3, and AvrRpm1Psy.
Proteins were extracted 5 hr after infection and
immunoblots were performed with RIN4 or
phospho-RIN4 T166 (pRIN4) antibodies.
(C) Arabidopsis does not recognize Pto
DC3000 expressing AvrRpm1Psy. Growth of Pto/
AvrRpm1Psy was not significantly different from
Pto/vector 3 dpi (n = 12; p > 0.05, t test).
(D) Bacterial growth inhibition of PsyDhopZ3 bac-
teria depends on AvrB3 and AvrRpm1Psy. Growth of
PsyDavrB3, PsyDavrRpm1Psy, and PsyDavrB3Davr
Rpm1Psy strains was not significantly different from
the WT PsyB728a in WT (Col) plants. PsyDhop
Z3DavrB3, PsyDhopZ3DavrRpm1Psy, and PsyDhop
Z3DavrB3DavrRpm1Psy mutants grew better than
PsyDhopZ3 in WT plants 3 dpi (ANOVA, Fisher’s
LSD, different letters indicate significant difference
p < 0.05; n = 20–28).
(E) Mutant complementation analysis of the ef-
fectors AvrB3 and AvrRpm1Psy. PsyB728a-deriv-
ative strains were infiltrated into Col (WT) plant
leaves. The growth of PsyDZ3DB3 and PsyDZ3DA1Psy strains expressing AvrB3 or AvrRpm1Psy was significantly reduced compared to vector controls 3
dpi (**p < 0.001, *p < 0.05, t test; n = 16).
(F) HopZ3 interferes with recognition of AvrRpm1 and AvrB. WT and HopZ3-expressing Arabidopsis (Z3 line 8 and Z3 line 9) were infiltrated with PtoDC3000
expressing AvrB, AvrRpm1, AvrRpt2, or empty vector. These experiments were performed at the same time. Note the increased growth of Pto/AvrB and Pto/
AvrRpm1 in plants that produce HopZ3 (*p < 0.05, t test; n = 8).
In all graphs, the following apply: Pto, PtoDC3000; Psy, PsyB728a; vector2, pME6012; vector 3, pVSP61; and error bars, SE. See also Figure S2.HopZ3 was specific, as it did not affect the growth of
PtoDC3000/AvrRpt2, which triggers the RPS2 immune receptor,
or PtoDC3000/vector with no known effectors that trigger immu-
nity in Arabidopsis (Figures 2F–2I). Thus, HopZ3 suppresses im-
munity triggered by effectors that activate RPM1 signaling.
HopZ3 Acetylates a Subset of Interacting Proteins and
Its Activity Is Needed for Promoting P. syringae Growth
on Arabidopsis
As HopZ3 is a member of the YopJ effector family, we tested
whether it can acetylate interacting proteins. Using in vitro
assays with 14C acetyl-CoA, we first established that HopZ3
has autoacetylation activity that is strongly stimulated by the
cofactor IP6 and dependent on the predicted catalytic Cys resi-
due (C300) (Figure 3A). This is consistent with a recent report that
only tested HopZ3 autoacetylation activity in the presence of IP6
in vitro (Ma et al., 2015). As expected, C300 was essential for
HopZ3 to promote both endophytic and epiphytic growth of
PsyB728a on Arabidopsis (Figures 3B and 3C). HopZ3 also
transacetylated the interacting plant proteins RIN4, RIPK,
PBS1, and BIK1 and the effectors AvrB and AvrB3 (Figures 3DCell Repand 3E; Figures S3A and S3B). As AvrRpm1Psy was insoluble
when expressed in E. coli, we used liquid chromatography-tan-
dem mass spectrometry (LC-MS/MS) analysis of proteins pro-
duced in planta to show that it was a HopZ3 substrate (Table 1).
The HopZ3 interactor MPK4 (Figure S3C), as well as the
non-interactor control HopIPsy (Figure 3E; Figure S3C), was not
acetylated by HopZ3. This indicates specificity of the acetyl-
transferase activity of HopZ3, despite the diversity in substrates.
Additionally, immunoprecipitation of transiently expressed
HopZ3, but not HopZ3_C300A, followed by immunoblotting
with an acetyl-lysine antibody showed that only WT HopZ3
was acetylated in planta (Figure 1F).
Thus, HopZ3 has acetyltransferase activity both in vitro and
within plant cells. Furthermore, the activity is needed for the viru-
lence effect of HopZ3.
Identification of Acetylation Sites in the HopZ3
Substrates
To gain insight into how HopZ3 might block immunity and to
confirm that acetylation of substrates occurs in planta, we deter-
mined the modification sites from HopZ3-acetylated proteinsorts 13, 1670–1682, November 24, 2015 ª2015 The Authors 1673
Figure 3. HopZ3 Acetylates Itself and Many
HopZ3-Interacting Proteins
(A) In vitro autoacetylation of His-HopZ3 (Z3) and
His-HopZ3_C300A (C/A) proteins in the presence
or absence of IP6 (inositol hexakisphosphate).
Progressively higher amounts (0.5–2 mg) of purified
His-HopZ3 or His-HopZ3 _C300A (C/A) were
incubated with [14C]-acetyl-CoA for 2 hr at RT,
separated by SDS-PAGE, and autoradiographed.
(B) The C300 residue in HopZ3 is required for
virulence. Only the bacterial population of
PsyDhopZ3/HopZ3 in Col was increased
compared to PsyDhopZ3/vector1 3 dpi (ANOVA,
Fisher’s LSD, different letters indicate significant
difference p < 0.5; n = 8).
(C) HopZ3 promotes epiphytic bacterial growth on
Col. PsyDhopZ3 expressing HopZ3 or
HopZ3_C300A was sprayed onto Arabidopsis.
Only bacterial population ofPsyDhopZ3was higher
than vector control (ANOVA, Fisher’s LSD; n = 24).
(D and E) HopZ3 acetylates RIPK, RIN4, AvrB, and
AvrB3. Purified recombinant His-tagged sub-
strates were incubated with His-HopZ3 or His-
HopZ3_C300A in the presence of [14C]-labeled
acetyl-CoA and IP6. Acetylated proteins were
detected by autoradiography. In (D), lanes 1–6 are
from one exposure of one continuous gel. Samples
in lanes 7–9 were run together and exposed at the
same time as lanes 1–6.
(F) HopZ3 is acetylated in planta. HopZ3-GFP
variants transiently expressed in N. benthamiana
were immunoprecipitated with GFP antibodies and
detected by immunoblotting (top, anti-acetylated
Lys; and bottom, anti-GFP). Protein levels were
estimated by densitometry using ImageJ (Gass-
mann et al., 2009) and expressed as a ratio. See
also Figure S3.using LC-MS/MS. To map acetylation sites on substrates, we
used both an in planta approach as well as in vitro assays with
recombinant proteins. For the in planta approach, we transiently
co-expressed HopZ3 and each substrate in N. benthamiana
followed by immunoprecipitation of the substrate. For in vitro as-
says, we developed a heavy isotope approach using 13C acetyl-
CoA to isotope label acetylation sites. This allowed us to
distinguish HopZ3-dependent acetylation from background
acetylation that may have occurred during protein production
in E. coli. For both approaches, HopZ3_C300A was used as a
control.
Mapped acetylation sites in RIPK, AvrB3, AvrRpm1Psy, and
RIN4 are shown in Table 1. In all cases, multiple acetylation sites
were found in the substrates. The majority of acetylation sites in
most substrates corresponded to conserved residues in paralo-
gous or homologous proteins (Table 1). In addition to Ser, Thr,
and Lysmodifications in several substrates, we found a His acet-
ylation site in AvrB3 (H221) (Table 1; Figure S4).
Some acetylation sites found in planta were absent in vitro.
Therefore, we examined our data for phosphorylation sites
that might competitively block acetylation (Table 1; Tables S2
and S3). S251, T252, and T257 of RIPK were phosphorylated
in protein produced in E. coli and used for in vitro reactions
(Table 1). By contrast, these sites were acetylated by HopZ31674 Cell Reports 13, 1670–1682, November 24, 2015 ª2015 The Auin planta (Table 1). Thus, phosphorylation of S251, T252, and
T257 in RIPK in vitro blocks their modification by HopZ3 (Ta-
ble 1; Table S3).
Structural modeling of RIPK and AvrB3 suggests that
HopZ3-mediated acetylation is targeted to important sites of
either catalysis or protein-protein interaction. Several of the
acetylation sites in RIPK were in structural proximity to the
ATP-binding site (K122, T164, S174, and S221), as well as
within the nearby activation loop (S251 and T252) (Figures
4A and 4B). Strikingly, two of the acetylation sites in AvrB3
(H221 and T137) (Figures 4C and 4D) correspond to residues
in AvrB (H217 and T125) that form a small hydrogen-bonding
network with T166 in RIN4 (Desveaux et al., 2007). The inter-
action of AvrB with RIN4 and RIPK is known to be reduced
when T125 is mutated (Desveaux et al., 2007; Liu et al.,
2011). These observations suggest that HopZ3-mediated acet-
ylation may functionally affect the targets through multiple
mechanisms.
Acetylation Sites in AvrB3 Are in Residues Important for
Immune Elicitation
Based on acetylation mapping, we hypothesized that HopZ3
modifies sites in other effectors that could be important for
recognition and/or activation of immunity. We tested this ideathors
Table 1. MS/MS Acetylated Residues that Depend on the Catalytic Activity of HopZ3; See Also Figure S4, Supplemental Experimental
Procedures, Data S1 and Tables S2 and S3
HopZ3-Interacting
Proteinsa
Acetylation
Siteb
Z3/Z3_C/A
Enrichment In Vitroc
Z3/Z3_C/A
Enrichment In Plantac Phosphod
Conserved Sites in
Paralogous or
Homologous Proteinse
RIPK i.v. (64%) i.p. (62%) S11 >10 1.1 i.v. 2/3
S47 NM >10 NM 0/3
K122 >10 NR NM 3/3
T137 1.0 >10 NM 2/3
T164 1.4 >10 NM 0/3
S174 1.9 6.5 NM 3/3
S184 NM 3.8 NM 0/3
S221 1.1 8.7 NM 3/3
S251 1.1 >10 i.v. 3/3
T252 1.1 >10 i.v. 3/3
T257 NM >10 NM 3/3
RIN4 i.v. (86%) i.p. (78%) K8 2.7 NR NM 6/7
S47 2.0 >10 i.p./i.v. 2/7
S49/51 1.5 1.4 NM 2/7, 0/7
S79 1.0 >10 NM 5/7
S83 1.1 >10 NM 0/7
K86 >10 >10 NM 4/7
S160 1.3 5.7 NM 3/7
S177/S178 2.9 1.2 NM 0/7, 2/7
AvrB3 i.v. (67%) i.p. (80%) S19 1.0 2.0 NM 2/4
T137 1.2 >10 NM 4/4
T185 NM >10 NM 3/4
H221 >10 2.2 NM 4/4
K229 NM 2.5 NM 2/4
T306 >10 2.5 NM 2/4
AvrRpm1Psy i.p. (79%) T137 ND 12.8 NM 4/4
T152 ND 3.5 NM 1/4f
aCoverage of substrates indicated for either in vitro (i.v.) or in planta (i.p.).
bSites were determined either in vitro using purified recombinant HopZ3/HopZ3_C300A and each substrate in the presence of IP6 and C
13-Acetyl-CoA
or in planta by co-expressing HopZ3/HopZ3_C300A and each substrate in N. benthamiana, followed by immunoprecipitation of the substrate.
cEnrichment of acetylation sites was determined by comparing the summedmaximum intensity of the isotopic distribution of the same acetylated pep-
tide in all three samples (containing HopZ3, HopZ3_C300A, or substrate alone). If the peptide modified by HopZ3 was not modified in either
HopZ3_C300A or substrate-alone samples, the sites were labeled as enriched >10. The values displayed are from comparing intensity of signals
from samples that contain HopZ3 versus HopZ3_C300A. NM, peptide recovered but not modified; NR, peptide not recovered; ND, not determined.
dPhosphorylation status of residue is as follows: i.v., in vitro; i.p., in planta; and NM, not modified.
eSequence conservation at each site with paralogous or homologous proteins using Clustal W. Number of paralogous or homologous proteins
analyzed in which the site was conserved is given (see the Supplemental Experimental Procedures and Data S1).
fIn other AvrRpm1 alleles, the cognate amino acid was S (see the Supplemental Experimental Procedures and Data S1).for AvrB3, since we could model its structure based on a
known crystal structure of AvrB with a fragment of RIN4. Previ-
ous mutational analysis of H217 and T125 in AvrB (RIN4-con-
tacting residues) (Desveaux et al., 2007) indicated that these
residues are important for inducing cell death (both) and/or
reduced bacterial growth (T125) (Desveaux et al., 2007). Site-
directed mutation of H221 or T137 abolished the ability of
AvrB3 to suppress bacterial growth during infection, but did
not affect the stability of the proteins in PsyB728a (Figure 5A).
Thus, at least some HopZ3-mediated acetylation sites affect
key functional residues in AvrB3.Cell RepAcetylation of Plant Immune Components by HopZ3
Affects Their Activity
RIPK and RIN4 are key players in the activation of RPM1 immu-
nity (Liu et al., 2011; Walter et al., 2004). Thus, we tested how
acetylation might affect their activity and function, respectively.
Using radiolabeled ATP, RIPK autophosphorylation was unaf-
fected by HopZ3_C300A, but was greatly inhibited after acetyla-
tion by HopZ3 (Figure 6A). Importantly, acetylation of RIPK
greatly reduced its ability to phosphorylate RIN4, a known sub-
strate (Figure 6B). Additionally, we noticed that HopZ3_C300A
was a substrate of RIPK, as evidenced by incorporation oforts 13, 1670–1682, November 24, 2015 ª2015 The Authors 1675
Figure 4. Acetylation Sites in Predicted 3D Structural Model of RIPK
and AvrB3
In models generated by iTASSER, mass spectral coverage is indicated by
color; cyan amino acids were seen in both in vitro and in planta experiments,
purple amino acids were only recovered in in vitro samples, and black amino
acids were not recovered. Unmodified versions of residues that were acety-
lated are shown as licorice versions in red. Functional analysis was performed
with residues marked by asterisks.
(A andC) Full protein models are shown for RIPK (A) and AvrB3 (C). The dashed
boxes indicate the area of the protein most acetylated in a HopZ3-dependent
manner.
(B and D) RIPK (B) and AvrB3 (D) are magnified from the dashed boxes in (A)
and (C). The protein in the foreground and background has been clipped to
provide a clearer view of the structural proximity of the residues targeted for
modification by HopZ3. In (B), shaded areas denote the ATP-binding site
(yellow) and the activation loop (green). K122 is a conserved Lys that co-
ordinates the g-phosphate of ATP upon nucleotide binding.
Figure 5. The Acetylation Sites of AvrB3 Are Important for Inducing
Immunity
H221 and T137 are required for AvrB3-mediated immunity during infection.
The bacterial population of PsyDavrB3DhopZ3 expressing AvrB3was different
than strains expressing mutated AvrB3 3 dpi in Col (ANOVA/Fisher’s LSD;
n = 36). (Lower panel) Expression of AvrB3-HA variants in PsyDavrB3DhopZ3
grown in KB medium (similar to the conditions before inoculation) was
analyzed by immunoblotting. 1, empty vector (vector1); 2, AvrB3-HA; 3,
AvrB3_H221R-HA; 4, AvrB3_T137A-HA.radiolabeled phosphate from ATP (Figure 6A). LC-MS/MS anal-
ysis of phosphopeptides after in vitro kinase reactions with
RIPK and HopZ3 confirmed that HopZ3 was also an RIPK sub-
strate (Figure S5).
According to our structural/homology model, the K122 and
S251/T252 residues that were modified by HopZ3-mediated
acetylation in RIPK are in the ATP-binding pocket and in the acti-
vation loop, respectively (Figure 4B). To assess whether these
residues are functionally important, we used site-directed muta-
genesis and in vitro modification assays. Mutation of either K122
or S251/T252 reduced the ability of RIPK to phosphorylate itself
as well as RIN4 (Figure 6C). The K122R and S251A/T252A vari-
ants of RIPK showed greatly reduced acetylation by HopZ3 (Fig-
ure 6D). When ripk mutant plants were infected, PsyDhopZ3
grew to the same level whether or not HopZ3 was added back,
consistent with RIPK being targeted by HopZ3 (Figure 6E).
We next tested whether acetylation of RIN4 by HopZ3 can
alter its ability to be phosphorylated by RIPK. To assess this,
RIN4 was acetylated by HopZ3 in vitro and then added to
RIPK in the presence of radiolabelled ATP. Acetylation of RIN41676 Cell Reports 13, 1670–1682, November 24, 2015 ª2015 The Auby HopZ3 reduced the ability of RIN4 to be phosphorylated by
RIPK in vitro (Figure 6F). In addition, when rin4 mutant plants
were infected, PsyDhopZ3 grew to the same level whether it
was complemented with HopZ3 or not (Figure 6G). Together,
our data indicate that HopZ3 can interfere with a key activating
event, phosphorylation of RIN4, by inhibiting the kinase activity
of RIPK and/or blocking the ability of RIN4 to be phosphorylated.
HopZ3 Suppresses RIN4 Phosphorylation Triggered by
AvrB3/AvrRpm1Psy during Infection
Induction of RIN4-pT166 is needed for RPM1 activation during
infection with PtoDC3000/AvrB or PtoDC3000/AvrRpm1 (Zhang
et al., 2010). If HopZ3 suppresses activation of RPM1, RIN4-
pT166 accumulation should be reduced during PsyB728a infec-
tion. To test this, we studied whether RIN4-pT166 occurred
during infection with PsyB728a and its dependence on different
effectors. PsyB728a modestly activated RIN4-pT166 accumula-
tion. Importantly, deletion of HopZ3 resulted in increased RIN4-
pT166 levels (Figure 6H), which correlated with suppression of
bacterial growth (Figure 1C). As expected, this accumulation
was largely due to AvrB3 and AvrRpm1Psy, since
PsyDhopZ3DavrB3DavrRpm1Psy showed reduced RIN4-pT166
levels relative to that induced by PsyDhopZ3 (Figure 6H). Thus,
HopZ3 suppressed the key signal activation step for RPM1 im-
munity, phosphorylation of RIN4 on T166.
DISCUSSION
This study established that acetylation on functionally important
Lys, Ser, Thr, and/or His residues by HopZ3 can reduce the
activity of an effector-immune complex. For the immune-stimu-
lating AvrB3 effector, HopZ3 can acetylate sites critical for
interactions with RIN4. For RIPK, HopZ3 can acetylate thethors
Figure 6. Acetylation of RIPK Affects Its
Activity
(A) Acetylated RIPK shows reduced autophos-
phorylation. GST-RIPK bound to GSH-agarose
was incubated with an increasing amount of His-
HopZ3 (Z3) or His-HopZ3_C300A (C/A) in the
presence of acetyl-CoA and IP6. Subsequently,
RIPK autophosphorylation was initiated by adding
[g-32ATP] and detected by autoradiography.
HopZ3 reduced RIPK autophosphorylation and
transphosphorylation of HopZ3 by RIPK.
(B) Acetylated RIPK reduced transphosphorylation
of RIN4.
(C) K122 and S251/T252 in RIPK are required for full
kinase activity. GST-RIPK phosphorylates itself
and RIN4, whereas GST-RIPK mutants show
reduced activity. Proteins were separated by SDS-
PAGE, stained with Coomassie blue (bottom), and
subjected to autoradiography (top).
(D) Acetylation of RIPK mutants by HopZ3 is
reduced. Acetylated proteins were detected by
autoradiography.
(E) HopZ3 suppresses RIPK-mediated immunity.
Populations of PsyDhopZ3 with or without HopZ3
were not different in ripk plants 3 dpi.
(F) Acetylation of RIN4 prevents its phosphorylation
by RIPK. Acetylated RIN4 is less efficiently
phosphorylated by RIPK. RIN4 bound to Ni-NTA-
agarose was acetylated by HopZ3, washed, and
then incubated with RIPK and [g-32ATP].
(G) HopZ3 suppresses RIN4-mediated immunity.
The growth of PsyDhopZ3 with or without HopZ3
was significantly different in rps2 RIN4, but not in
rps2 rin4 3 dpi. (rps2 was used to avoid the dele-
terious effect of rin4).
(H) HopZ3 blocks RIN4 phosphorylation during
infection. PsyB728a, PsyDhopZ3, and Psy
DhopZ3DavrB3DavrRpm1Psy were infiltrated at
OD600 = 0.1 into leaves of Col (WT) and samples
were collected at the indicated hours post-infec-
tion (hpi); 10 mM MgSO4 (Mock) treatments were
used as negative controls. Immunoblots were
performed with either anti-RIN4 or anti-phos-
pho-RIN4 T166 (pT166) antibodies. See also
Figure S5.nucleotide-binding site and activation loop to reduce kinase ac-
tivity. Finally, for RIN4, HopZ3-mediated acetylation can reduce
RIN4’s ability to be phosphorylated by RIPK, a necessary step in
activation of RPM1 signaling.
Our data suggest that targeting multiple members of a major
effector-immune complex could be an effective way for HopZ3
to inactivate the complex and suppress defense signaling. By
partially reducing the activity of multiple components, the
outcome can be selected to accommodate conflicting require-
ments for maintaining virulence functions of effectors while
reducing their defense-inducing recognition by plants. To elab-
orate this hypothesis, it is necessary to determine which spe-
cific acetylation and other PTMs occur in effector-immune
complexes during infection. This requires technical advances
to scale up purification of protein complexes for analysis by
mass spectrometry (MS) and/or development of new reagents
to detect specific acetylated residues of whole proteins of
interest.Cell RepInterestingly, P. syringae strains other than PsyB728a also har-
bor alleles of HopZ3, AvrB, and AvrRpm1 or other effectors
whose defense-inducing activities can be suppressed by
HopZ3 (Table S4). These strains also may use a similar mecha-
nism to that described in this work. Our finding that effector-
effector interactions may contribute to reduced defense
activation adds to the range of strategies in which effectors are
deployed by pathogens to ameliorate the detection of other
effectors.
Surprisingly, in the context of infection with PsyDhopZ3, both
AvrB3 and AvrRpm1Psy are needed to activate immunity. Since
these effectors interact in planta, they may act cooperatively,
possibly by stabilizing each other, to activate the immune com-
plex. We do not know of another example of a physically inter-
acting effector pair in P. syringae where both effectors are
simultaneously needed to stimulate the same immune pathway.
The closest similarity may be AvrPto and AvrPtoB, which
contribute additively to immune activation in tomato throughorts 13, 1670–1682, November 24, 2015 ª2015 The Authors 1677
interaction with protein complexes that involve the immune regu-
lator Prf (Lin and Martin, 2005).
Our study demonstrates that HopZ3 functionally interferes
with the immune-activating properties of both AvrB3 and
AvrRpm1Psy. Although there are other examples of effector epis-
tasis (Jamir et al., 2004; Szczesny et al., 2010; Tamaki et al.,
1988; Tsiamis et al., 2000), this work implicates a plausible
mechanism wherein one effector may directly modify others.
Additional effector enzymes (Feng et al., 2012; Mackey et al.,
2003; Rosebrock et al., 2007; Wang et al., 2010) may similarly
modify both plant proteins and pathogen effectors.
We found that two HopZ3 Arabidopsis transgenic plant lines
suppress immune activation by AvrB and AvrRpm1, as
measured by changes in pathogen growth after low-dose infec-
tions. In contrast, a similar plant line expressing HopZ3 was un-
able to interfere with immunity-associated cell death induced by
several effectors during high-dose infections (Lewis et al., 2014).
Pathogen growth can sometimes be uncoupled from macro-
scopic symptoms, which may explain the different results
obtained.
Effector-effector interactions are an understudied and often
overlooked virulence strategy. It seems possible that bacterial
effectors may form multi-protein complexes (such as HopZ3/
AvrB3/AvrRpm1Psy) to better target host components. Such in-
teractions might allow whole effector complexes to form stable
interactions with plant proteins inside plant cells, while reducing
detectability by plant defense systems. Something similar to this
is seen in the human pathogen Chlamydia trachomatis, where
two type III Inc effectors interact and co-localize with Src family
kinases in the membrane that surrounds the vacuolar compart-
ment in which the pathogen resides (Mital et al., 2010). The
observation that AvrB3 can affect the localization of HopZ3 is
consistent with these findings.
This study documented a new stable acetylation modification
on a key His residue in addition to the established YopJ family
acetylation modifications on Lys, Ser, and Thr residues (Mukher-
jee et al., 2006; Trosky et al., 2007). His acetylations have not
been widely reported in any system. A kinase substrate of
YopJ may have a His modification, but its dependence on
YopJ catalytic activity has yet to be validated (Paquette et al.,
2012). Previous work using nuclear magnetic resonance (NMR)
showed that a chemically induced acetylation of a Lys residue
in ubiquitin occurred via an unstable acetylated His intermediate
(Macdonald et al., 2000). Therefore, it seems possible that some
acetyltransferase-mediated His acetylations may be unstable
and, thus, could have been missed in previous analyses. Our
finding of a His acetylation modification in AvrB3 suggests that
His modifications should be examined carefully in other acetyl-
transferase substrates.
In addition to suppressing AvrB3/AvrRpm1Psy-triggered im-
munity (this study), HopZ3 suppresses flg22 responses (Lewis
et al., 2014). Interestingly, HopZ3 interacts with and/or acety-
lates RLCK family members (BIK1 and PBL1) with known roles
in flg22 signaling. How acetylation mechanistically blocks flg22
response proteins will be an interesting area for future studies.
We found two examples of HopZ3-mediated acetylation that
overlap with identified phosphorylation sites in RIN4, S47 and
T160 (Chung et al., 2014; Liu et al., 2011; N€uhse et al., 2004,1678 Cell Reports 13, 1670–1682, November 24, 2015 ª2015 The Au2007). Although these sites individually have no known biological
function, competitive PTM of S47 and T160 possibly together
with other modifications in RIN4 during infection might control
RIN4 function. Xanthomonas AvrAC modifies the same sites as
HopZ3 in RIPK (S251 and T252) within the activation loop
(Feng et al., 2012). In the case of AvrAC, the modification in-
volves the addition of uridine 5-monophosphate. Whether AvrAC
also modifies other members of the RPM1 immune complex or
other effectors remains to be investigated.
In summary, this work established that an effector-immune
complex can bemodified and inactivated by acetylation. This ex-
plains why loss of the HopZ3 effector from PsyB728a causes
greatly reduced pathogen growth on Arabidopsis genotypes
that have a functional RPM1 pathway. Interestingly, HopZ3-
mediated acetylation may affect effector-immune complex com-
ponents through multiple mechanisms by (1) inactivating a
kinase, (2) modifying protein-protein interaction sites needed
for signal activation, and (3) preventing other PTMs.
EXPERIMENTAL PROCEDURES
All genes were amplified by PCR using primers that incorporated a specific re-
striction enzyme site or att domain (Table S7). All PCR products were trans-
ferred into the pDONR207 following the Gatewaymanual using the BP clonase
enzyme mix (Invitrogen) and were sequence validated. To clone into pENTR
vectors, genes were recombined into nYFP (pG005, The European Arabidop-
sis Stock Centre), cYFP (pG006, The European Arabidopsis Stock Centre),
pLaw10 (which contained Gal4 DNA-binding domain), and pLaw11 (which
contained the Gal4 activation domain) using the LR clonase enzyme mix, ac-
cording to themanufacturer’s instructions (Invitrogen). The site-directedmuta-
genesis was generated by PCR using overlapping primers incorporating the
mutation of interest (Table S5). Point mutants were cloned into either a
pET28a or pGEX 4T-3 TEV vector and sequenced to ensure that no additional
mutations were introduced.
Strains and Plasmids
Bacteria strains and plasmids are listed in Tables S5 and S6.
Protein Production and Purification
To purify GST and His fusion proteins, E. coli BL21 (DE) cells transformed with
GST or His-tagged constructs were induced at an optical density 600 (OD600)
of 0.6–0.8 with 0.2mM isopropyl-b-d-thiogalactopyranoside for 2–5 hr at 30C.
Cellular extracts were made by sonication and clarified at 10,000 3 g for
20 min. GST fusion proteins were purified by binding to glutathione-conju-
gated beads and eluted with reduced glutathione (GE Healthcare). His fusion
proteins were purified by binding to Ni-NTA agarose beads (QIAGEN) and
then eluted with 300 mM imidazole.
Plant Lines and Growth Conditions
Plant growth chamber conditions were as described previously (Lu et al.,
2003). Dexamethasone-inducible constructs encoding HopZ3-HA:pBAV154
(Lee et al., 2012b) were transformed into Agrobacterium GV3101. Transgenic
Col-0 Arabidopsis plants were generated by a floral dip transformation proce-
dure (Bent, 2006). All other Arabidopsis lines (rps2, rps2rin4, ripk, and rpm1)
were described previously (Belkhadir et al., 2004; Liu et al., 2011; Mackey
et al., 2002). Nicotiana benthamiana was used for transient expression studies
as described previously (Lee et al., 2012b).
Generation of Mutant Bacteria and Complementation Constructs
Strains bearing deletions of AvrB3 and/or AvrRpm1Psywere constructed using
sacB-mediated negative selection as described previously (Vinatzer et al.,
2006), except that the pMTN1907 vector was used (Baltrus et al., 2012). Mu-
tants were confirmed by PCR amplification of the deletion. To complement
the mutant phenotype, the WT AvrB3 and AvrRpm1Psy were cloned intothors
pBAV226 (Vinatzer et al., 2006). This construct was then introduced into the
PsyDhopZ3 DavrB3 or PsyDhopZ3 DavrRpm1Psy double-mutant strains by
electroporation.
Bacterial Growth Assays
Overnight cultures of P. syringae were diluted 1:10 and grown for 3 hr at 30C.
The bacteria (OD600 = 0.0001 or 0.0003 for PtoDC3000 and 0.0003 for
PsyB728a derivatives) were syringe infiltrated into at least 8–28 leaves of Ara-
bidopsis plants (21–24 days old). To measure epiphytic growth, Arabidopsis
plants were sprayed with PsyB728a derivatives at an OD600 = 0.03 (in
10 mM MgSO4 without additives) and covered with a dome without holes for
3 days. For evaluation of bacterial growth, eight 1-cm2-diameter leaf disks
for each strain were either homogenized by mechanical disruption or vortexed
to collect epiphytic bacteria in 200 ml of 10 mMMgSO4. Samples were serially
diluted and enumerated by counting colony-forming units after plating on LB
agar containing antibiotics. All experiments were repeated two to three times
with similar results.
Acetylation Assays
In vitro acetylation assays using radiolabel were performed as previously
described (Jiang et al., 2013; Lewis et al., 2013). Purified substrates (1–3 mg)
and 1 mg purified His-HopZ3 or His-HopZ3_C300A were mixed with acetyla-
tion reaction mixture containing 50 mM HEPES (pH 8.0), 10% glycerol, 5 mM
IP6, and 1–2 ml
14C-Acetyl-CoA (56 mCi/mM) (PerkinElmer) in a total volume of
20 ml. All acetylation reactions were incubated at room temperature (RT) for
2–3 hr and terminated by the addition of SDS-PAGE loading buffer and boiling
for 5 min. Proteins were separated by SDS-PAGE. After electrophoresis, gels
were dried on 3M paper and exposed to X-ray film for 3–14 days. Each data
point consisted of at least two replicates. Heavy isotope in vitro as well as
in vivo acetylation assays for LC-MS/MS-based mapping are provided in the
Supplemental Experimental Procedures.
In Vitro Kinase Assay
For RIPK auto- and transphosphorylation assays, 0.5 mg GST-RIPK, GST-
RIPK (T251A/T252A), and GST-RIPK (K122R) proteins and 3 mg RIN4 were
incubated with phosphorylation mix (10 mM MgSO4, 10 mM ATP, and
10 mM g [32P]-ATP) for 30 min at RT. To evaluate the influence of acetyla-
tion on RIPK kinase activity, reactions of protein bound to glutathione beads
were performed. Bead-bound GST-RIPK (0.5 mg) and the purified His-HopZ3
(0.25, 0.5, and 1 mg) or His-HopZ3_C300A (0.25, 0.5, and 1 mg) were first
incubated in acetylation reaction mixture (50 mM HEPES [pH 8.0], 10% glyc-
erol, 5 mM IP6, and 50 mM acetyl-CoA; Sigma) for 2 hr at RT or 16 hr in a cold
room (4C). After washing the beads with the washing buffer (50 mM
HEPES [pH 8.0], 50 mM NaCl, and 10% glycerol), the phosphorylation reac-
tion was initiated by adding phosphorylation mix (10 mM MgSO4, 10 mM
ATP, and 10 mM g [32P]-ATP; PerkinElmer) for 30 min at RT. To determine
the level of RIN4 phosphorylation by RIPK after acetylation by HopZ3, bead-
bound His-RIN4 (3 mg) was incubated with His-HopZ3 (1 mg) and His-
HopZ3_C300A (1 mg) in acetylation reaction mixture for 2 hr at RT. After
washing the beads twice, the phosphorylation reaction was initiated by add-
ing 0.5 mg RIPK with the phosphorylation mix for 30 min at RT. All reactions
were terminated by adding Laemmli buffer and boiling for 5 min. Proteins
were separated by 12% SDS-PAGE and signals were visualized by X-ray
film exposure for 16 hr. All experiments were repeated two to three times
with similar results.
BIFC Assay
Constructs and vectors used in this work are listed in Table S6. Each test pro-
tein coding sequencewas cloned into either the pG005 vector, which fused the
N-terminal half of YFP (nYFP, 1–155 amino acid [aa]) to the C terminus of the
protein, or was cloned into the pG006 vector, which fused the C-terminal half
of YFP (cYFP, 156–239 aa) to the C terminus of the protein. Binary plasmids
with a helper pSoup were transformed into A. tumefaciensGV3101 by electro-
poration. Co-infiltration of Agrobacteria containing the BIFC constructs into
N. benthamiana leaves was done at a final concentration of OD600 = 0.8.
Epidermal cells of N. benthamiana leaves were assayed for fluorescence
48 hr after agroinfiltration. YFP fluorescence (visible only when proteins fusedCell Repto YFP halves interact) was visualized using a Zeiss LSM710 confocal laser-
scanning microscope by excitation with a single line 488-nm laser, and emis-
sion was collected with filter set to 489–573 nm. All experiments were repeated
two times with similar results.
Subcellular Fractionation
A. tumefaciens strain C58C1 bacteria carrying pBAV150-HopZ3 and
pBAV154-AvrB3 or AvrB3_G2A binary vector, respectively, were transiently
co-infiltrated into N. benthamiana leaves (Lee et al., 2012b). Two days after
the infiltration of Agrobacteria, expression of transgenes was induced by
spraying 30 mM dexamethasone on the plant leaves. After 16 hr, leaf sam-
ples were harvested for subcellular fractionation and immunoblotting as
described in a previous report (Lu et al., 2003). Briefly, samples were ground
with grinding buffer (50 mM Tris-HCl [pH 7.5], 0.33 M sucrose, 5 mM EDTA,
and 1 mM DTT; Roche) and then centrifuged at 10,000 3 g at 4C to pellet
insoluble material. Supernatant was ultracentrifuged at 100,000 3 g at 4C
for 1 hr to precipitate total membrane fraction. After partitioning, the super-
natant and the pellet were used as soluble and membrane fractions, respec-
tively. After separation by SDS-PAGE and transfer to PVDF membranes,
proteins were probed with anti-GFP (Covance), anti-HA (Covance,
1:1,000), anti-H+-ATPase (Agrisera, 1:7,500), and anti-cFBP (Agrisera,
1:20,000) antibodies. The experiment was repeated two times with similar
results.
Yeast Two-Hybrid Assay
Yeast two-hybrid assays were analyzed based on the requirement of His for
yeast growth and expression of the lacZ gene reporter (Cantu et al., 2013).
More detailed methods are provided in the Supplemental Experimental
Procedures.
Immunoblotting Assay
For HopZ3-GFP immmunoprecipitation, pBAV150-derived constructs with
HopZ3 or pBAV150-HopZ3_C300A were used to transiently express proteins
in N. benthamiana after agroinfection. Plants were treated with 30 mM dexa-
methasone for 16 hr to induce HopZ3-GFP expression. Proteins were ex-
tracted with lysis buffer (50 mM Tris [pH 7.5], 50 mM NaCl, 1 mM EDTA,
1 mM DTT, and 0.2% Triton X-100) containing protease inhibitor (Roche),
phosphatase inhibitor (Thermo Scientific), and 3 mM TrichostatinA (Sigma).
Clarified total protein lysate was incubated for 3 hr with antibody directed
against full-length GFP (Clontech Laboratories) at 4C followed by incubation
for 1 hr with 30 ml fast-flow protein A agarose beads (Roche). After washing the
beads three times with the lysis buffer, proteins were eluted by boiling with
Laemmli loading buffer. Samples were analyzed by western blotting with
anti-GFP (1:5,000) and anti-acetylated Lys (1:1,000) antibody (Cell Signaling
Technology).
For detecting RIN4 phosphorylation in Arabidopsis, 21–24 old plants were
infiltrated with PtoDC3000- and PsyB728a-derived strains at OD600 = 0.1.
Leaf tissue was collected 6, 18, and 24 hr after infections for protein analysis.
Arabidopsis leaves were ground in liquid nitrogen and resuspended in lysis
buffer including phosphatase inhibitor (Roche). The resulting samples were
analyzed by western blotting and probed with anti-pRIN4 (1:1,000, a gift
from Dr. Gitta Coaker at University of California, Davis) and anti-RIN4
(1:5,000, a gift from Dr. Gitta Coaker) antibodies (Liu et al., 2011). The experi-
ment was repeated two times with similar results.
Structural Modeling
To assess the relevance of the acetylated residues found by MS, we
modeled the structure of the HopZ3 substrates using the Iterative Threading
Assembly Refinement (iTASSER) structural prediction software (Roy et al.,
2010; Yang et al., 2015; Zhang, 2008). The top models were assessed for
the best possible model based on confidence score (C-score) calculated
based on the significance of threading to the template alignments and
convergence to the parameters of the structural assembly simulations (Roy
et al., 2010; Yang et al., 2015; Zhang, 2008). Model visualizations were
generated using VMD 1.9.1, using the new cartoon setting coloring by MS
coverage as indicated in the figure legend. Acetylation sites were labeledorts 13, 1670–1682, November 24, 2015 ª2015 The Authors 1679
using the licorice setting and coloring red; however, the sites shown are not
acetylated in the model.
LC-MS/MS Analysis
MS was performed at the Medical Genome Facility Proteomics Core at Mayo
Clinic. Additional (more detailed) methods are provided in the Supplemental
Experimental Procedures.
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The MS data have been deposited in ProteomeCentral (http://
proteomecentral.proteomexchange.org) via the PRIDE partner repository
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